1. US Food and Drug Administration. Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims. PRO definition. Available from: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/patient-reported-outcome-measures-use-medical-product-development-support-labeling-claims (Last accessed: 13 January 2024).
2. US Food and Drug Administration. Clinical outcome assessments definition. Available from: https://www.fda.gov/science-research/focus-areas-regulatory-science-report/focus-area-patient-reported-outcomes-and-other-clinical-outcome-assessments (Last accessed: 15 January 2024).
3. Patient-reported outcomes (PROs) and patient-reported outcome measures (PROMs);Weldring;Health Serv Insights,2013
4. EU Commission. Deaths and disability-adjusted life years within the EU in 2019 from non-communicable diseases. Available from: https://knowledge4policy.ec.europa.eu/health-promotion-knowledge-gateway/eu-burden-non-communicable-diseases-key-risk-factors-1_en_en (Last accessed: 20 March 2024).
5. The Assessment of Patient-Reported Outcomes for the Authorisation of Medicines in Europe: A Review of European Public Assessment Reports from 2017 to 2022;Meregaglia;Appl Health Econ Health Policy,2023